$PEBK

PEOPLES BANCORP OF NORTH CAROLINA INC (PEBK): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

PEOPLES BANCORP OF NORTH CAROLINA INC (PEBK) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. pebk_8k.htm 0001093672 false false Common Stock, no par value 0001093672 2026-07-16 2026-07-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE

Original reporting
Published Jul 21, 2026, 3:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 21, 2026, 3:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$PEBK
Neutral
high confidence
Mentioned
$PEBK
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PEBKNeutralLow
01

Why it matters

The disclosure is limited to the election of Michael B. Hollar to the boards, with statements that there are no related-party transactions and no family relationships, and that he is not yet appointed to board committees.

02

Market read

A routine board election with no disclosed material transactions or committee roles, suggesting minimal near-term trading impact.

03

What to watch

The filing does not mention committee assignments or compensation details; traders may need to check subsequent filings or proxy materials for any material governance or compensation implications.

Relevance 6/10Novelty 3/10Timing: post-filing, same-day governance update on July 21, 2026

Background

This is an SEC Form 8-K (Item 5.02) reporting the election of a director to Peoples Bancorp of North Carolina, Inc. and its wholly-owned subsidiary, Peoples Bank.

Company-level read

Ticker impact

$PEBKNeutralHigh confidence
Context

PEBK disclosed via 8-K that its boards elected Michael B. Hollar to the Company and Peoples Bank boards on July 16, 2026.

Expected impact

Likely limited immediate price impact; any reaction would be modest unless the filing also implied material strategy or risk changes (not stated here).

Evidence & confidence

The filing only states the election of a director, with no disclosed related-party transactions, committee assignments, or other material changes.

Market effects

Bank governance updates can marginally influence investor sentiment, but this specific disclosure lacks new financial or regulatory developments.

No specific regional credit, deposit, or regulatory event is disclosed.

No global linkage; the event is company-specific and governance-related.

Counterpoint

The market may ignore routine board elections, but if the appointee has relevant banking/regulatory expertise, the appointment could be a subtle signal of upcoming strategic shifts not captured in this brief text.

Key entities

  • PEBK

    Peoples Bancorp of North Carolina, Inc., the registrant filing the 8-K.

  • Michael B. Hollar

    Elected to the boards of Peoples Bancorp of North Carolina, Inc. and Peoples Bank on July 16, 2026.

  • Peoples Bank

    Wholly-owned subsidiary whose board also elected Michael B. Hollar.

Related articles

$PEBKMed

PEOPLES BANCORP OF NORTH CAROLINA INC (PEBK): Results of Operations and Financial Condition

PEOPLES BANCORP OF NORTH CAROLINA INC (PEBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.A 2 pebk_ex99a.htm PRESS RELEASE pebk_ex99a.htm EXHIBIT (99)(a) EARNINGS RELEASE July 20, 2026 Contact: William D. Cable, Sr. President and Chief Executive Officer Jeffrey N. Hooper Executive Vice President and Chief Financial Officer 828-464-5620 For Immediate Release PEOP

$GSMed

Goldman’s board has discussed plan to name John Waldron as next CEO, WSJ reports

Goldman Sachs' board has reportedly discussed a plan for CEO David Solomon to step down and be replaced by COO John Waldron by 2028, with Solomon potentially becoming executive chairman. The bank declined to comment, and shares were unchanged in after-hours trading. According to the Wall Street Journal, the plan requires board approval and could be finalized in the coming months.

$005930.KSMedAI 8/10

Samsung commits $1 billion to help build the infrastructure AI needs

Samsung is investing $1 billion in Helix Digital Infrastructure to support global AI infrastructure development. Helix, backed by investors including KKR and NVIDIA, focuses on AI-enabling infrastructure. Samsung's expertise in technology, construction, and energy storage will aid Helix's projects. Helix aims to meet the growing demand for AI infrastructure from hyperscalers.

$NVDAHighAI 8/10

Nvidia boosts share buyback program by record $150B

Nvidia Corp. plans to spend $150B on share buybacks through 2028, the largest-ever expansion of such a program. The company also plans to increase its dividend. Nvidia cited rapid revenue growth and strong performance of its startup investment portfolio as reasons. It ended its fiscal second quarter with $22.44B in cash and expects sales to increase by 70% in fiscal 2028. The company's revenue growth is driven by its expanding product lineup and successful investment portfolio.

$AZNHighAI 9/10

AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs

AstraZeneca will invest $2 billion in Summit Therapeutics via convertible preferred shares at a 10% premium. The companies will collaborate on cancer treatments, including a clinical trial for gastrointestinal cancers. Summit's shares rose 18% in after-hours trading, while AstraZeneca's shares remained unchanged. The deal is expected to close this week, according to Summit.